Tibolone: a compound with tissue specific inhibitory effects on sulfatase

Molecular and Cellular Endocrinology
Marcel E de GooyerH J Kloosterboer

Abstract

The aim was to test whether sulfatase activity is differently regulated by tibolone in human bone, endometrium and breast cells since selective inhibition of sulfatases in various tissues may contribute to the tissue-specificity of tibolone. Tibolone, its 3 alpha- and 3 beta-hydroxy metabolites and their 3-sulfated forms, and its Delta(4)-isomer strongly (70-90%) inhibited the sulfatase activity in human breast cell lines (two T-47D clones) and intermediately (8-43%) in human endometrial cells (HEC-1A). In contrast, they did not inhibit sulfatase in two human osteoblast-like cell lines (MG 63, HOS TE-85). The specific sulfatase inhibitor, EMATE, showed inhibition in all cell lines. Just as estrone sulfate, 3 alpha-sulfated tibolone was also converted by sulfatase to the unconjugated 3 alpha-hydroxy-tibolone intracellularly in all cell lines. The tissue specific inhibition pattern of sulfatase activity by tibolone and its metabolites suggest that tibolone could be protective against development of mammary carcinomas, whereas it retains favorable estrogenic effects on bone.

References

Jul 1, 1987·The Journal of Clinical Endocrinology and Metabolism·L Milewich, J C Porter
Jan 1, 1987·Maturitas·L TaxP M Kicovic
May 1, 1986·Journal of Steroid Biochemistry·S GullerE Gurpide
Jan 3, 1980·The New England Journal of Medicine·I C Henderson, G P Canellos
Jun 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·H J KloosterboerJ G Klijn
Jan 1, 1997·The American Journal of the Medical Sciences·M Notelovitz

❮ Previous
Next ❯

Citations

May 3, 2005·The Journal of Steroid Biochemistry and Molecular Biology·B RaobaikadyM J Reed
Dec 12, 2002·Steroids·Marcel E de GooyerHelenius J Kloosterboer
Mar 26, 2003·The Journal of Steroid Biochemistry and Molecular Biology·H J Kloosterboer, A G H Ederveen
May 10, 2005·Menopause : the Journal of the North American Menopause Society·Iolente J M KorstjensPieter Sipkema
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Andrea R GenazzaniHelenius J Kloosterboer
Apr 29, 2006·Menopause : the Journal of the North American Menopause Society·Petra StuteJ Mark Cline
Jan 17, 2007·Menopause : the Journal of the North American Menopause Society·Erica J M Velthuis-Te WierikCarlos Martinez
Jan 24, 2007·Menopause : the Journal of the North American Menopause Society·Melloney J DrögeHelenius J Kloosterboer
Sep 29, 2006·Menopause : the Journal of the North American Menopause Society·Stephen G SwansonVictoria M Stathopoulos
Sep 1, 2006·Neuropsychiatric Disease and Treatment·Andrea Riccardo GenazzaniMichele Luisi
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G H DeckersH J Kloosterboer
Sep 29, 2011·Climacteric : the Journal of the International Menopause Society·H J Kloosterboer
Sep 27, 2005·Climacteric : the Journal of the International Menopause Society
Jul 20, 2007·Taiwanese Journal of Obstetrics & Gynecology·Peng-Hui WangKuan-Chong Chao
Mar 17, 2009·The Journal of Sexual Medicine·Rossella E Nappi, Franco Polatti
Dec 6, 2007·The Breast : Official Journal of the European Society of Mastology·P KenemansJ Planellas
Nov 23, 2006·The Journal of Steroid Biochemistry and Molecular Biology·H A M Verheul, H J Kloosterboer
Sep 8, 2004·Maturitas·H J Kloosterboer
May 18, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Josie L FalanyCharles N Falany
Jan 30, 2009·Climacteric : the Journal of the International Menopause Society·E A NijlandUNKNOWN LISA study investigators group
Aug 23, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·John Eden
Jan 28, 2010·Expert Opinion on Drug Metabolism & Toxicology·Martin SvobodaTheresia Thalhammer
Apr 2, 2008·Expert Opinion on Pharmacotherapy·Gordana LazovicJelena Marinkovic
Dec 17, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Trevor M PenningYi Jin
Jul 4, 2006·American Journal of Obstetrics and Gynecology·Wei ZhangLinda Tseng
May 1, 2007·The Journal of Steroid Biochemistry and Molecular Biology·B RaobaikadyA Purohit
Nov 13, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·M L HammarUNKNOWN TOTAL Study Investigators Group
Jul 25, 2019·Journal of Neuroendocrinology·Oscar Hidalgo-LanussaGeorge E Barreto
Feb 3, 2009·Menopause : the Journal of the North American Menopause Society·Michelle L Van SinderenMargaret E E Jones
Nov 25, 2004·Endocrine Reviews·M J ReedB V L Potter
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·L J BlokC W Burger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Steroid Biochemistry and Molecular Biology
Josie L FalanyCharles N Falany
The Journal of Steroid Biochemistry and Molecular Biology
H J Kloosterboer
Drug Metabolism and Disposition : the Biological Fate of Chemicals
R M E VosL P C Delbressine
© 2021 Meta ULC. All rights reserved